HSI Donesafe and Neopharma Integrate Fit-For-Duty Workflows for Compliance

The announcement of the API integration between HSI Donesafe and Neopharma Technologies marks a significant shift in how high-risk industries approach workforce readiness and regulatory compliance. By embedding Neopharma’s NEOVAULT and DRUID technologies into the Donesafe ecosystem, the partnership addresses a long-standing gap in safety management: the disconnect between general safety reporting and specific Fit-For-Duty (FFD) protocols. Historically, drug and alcohol testing results have been siloed in disparate databases or maintained on paper, making it difficult for safety officers to gain a real-time, holistic view of site risk. This integration effectively bridges that gap, allowing for a more cohesive approach to risk management.

At the heart of this integration is the DRUID functional impairment assessment. Unlike traditional biological testing, which identifies the presence of substances but not necessarily the level of impairment, DRUID provides a one-minute cognitive and psychomotor evaluation. This allows organizations to detect impairment caused by a variety of factors, including fatigue, stress, illness, or psychosocial hazards. For legal and compliance teams, this represents a transition from reactive monitoring to proactive risk mitigation. By establishing personal baselines for employees, the system can flag meaningful performance deviations, providing a data-driven justification for intervention before an incident occurs, rather than relying solely on post-incident testing.

“

By embedding Neopharma’s NEOVAULT and DRUID technologies into the Donesafe ecosystem, the partnership addresses a long-standing gap in safety management: the disconnect between general safety reporting and specific Fit-For-Duty (FFD) protocols.

From a regulatory perspective, the integration strengthens the Officer Due Diligence framework required under modern Work Health and Safety (WHS) legislation. Corporate officers are increasingly held personally liable for ensuring that their organizations have robust systems in place to manage known risks. The unified workflow provided by Donesafe and Neopharma creates a continuous, auditable chain of custody and decision-making. When an impairment is detected, the subsequent actions—ranging from re-testing to standing down a worker—are recorded within the same governance framework used for all other safety actions. This creates a defensible record that is critical during regulatory audits or post-incident investigations, where proving a systematic approach to safety is paramount.